Anti-spike protein to determine SARS-CoV-2 antibody levels: Is there a specific threshold conferring protection in immunocompromised patients?

Philippe HalfonSylvie JordanaStéphane BlachierPhilippe CartlamyLaurent KbaierChristina K PsomasPatrick PhilibertGilles AntoniottiJulie Allemand-SourrieuStanislas RebaudetGuilhem CavailleChloé StavrisFrédérique RetornazLaurent ChicheGuillaume Pénaranda

Published in: PloS one (2023)

We suggest specific adjusted thresholds (BAU/ml) for the four commercial antibody assays that are used to assess pre-exposure prophylaxis in immunocompromised patients.

Keyphrases

end stage renal disease
sars cov
chronic kidney disease
ejection fraction
peritoneal dialysis
newly diagnosed
prognostic factors
patient reported outcomes
intensive care unit
coronavirus disease